Atacicept Demonstrating Dose RESponSe

NCT01440231 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Placebo
DRUG: Atacicept
DRUG: Atacicept
DRUG: Atacicept
DRUG: Atacicept

Sponsor

EMD Serono